Recent progresses in combination cancer therapy using cyanine dye-based nanoparticles
Pharmaceutical Science Advances · 2024-12 · 2 · 100040
DOI: 10.1016/j.pscia.2024.100040 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutical Science Advances, 2024-12. Verfasst von Qian An und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, 430071, China. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, 430071, China.
- Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Wuhan University, Wuhan, Hubei, 430071, China.
- TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, Hubei, 430071, China.
Zitieren
APA
An, Q., Xiang, S. R., & Zou, Y. Q. (2024). Recent progresses in combination cancer therapy using cyanine dye-based nanoparticles. Pharmaceutical Science Advances, 2, 100040. https://doi.org/10.1016/j.pscia.2024.100040
Vancouver
An Q, Xiang SR, Zou YQ. Recent progresses in combination cancer therapy using cyanine dye-based nanoparticles. Pharmaceutical Science Advances. 2024;2:100040. doi:10.1016/j.pscia.2024.100040
BibTeX
@article{An2024,
author = {An, Qian and Xiang, Si-Rui and Zou, You-Quan},
title = {Recent progresses in combination cancer therapy using cyanine dye-based nanoparticles},
journal = {Pharmaceutical Science Advances},
year = {2024},
volume = {2},
pages = {100040},
doi = {10.1016/j.pscia.2024.100040}
}
EUVIMED